Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $697.6100 (-0.35%) ($686.8050 - $704.9650) on Wed. Sep. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.95% (three month average) | RSI | 69 | Latest Price | $697.6100(-0.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 3% a day on average for past five trading days. | Weekly Trend | REGN advances 10% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(35%) IWD(33%) SPLV(32%) SDY(30%) | Factors Impacting REGN price | REGN will decline at least -1.475% in a week (0% probabilities). TBT(-9%) VIXM(-6%) UUP(-5%) VXX(-1%) KWEB(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.475% (StdDev 2.95%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $707.96(-1.46%) | 10 Day Moving Average | $650.49(7.24%) | 20 Day Moving Average | $629.28(10.86%) | To recent high | -3.7% | To recent low | 27.4% | Market Cap | $73.967b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |